Article
Emergence of drug resistance mutations in a group of HIV-infected children taking nelfinavir-containing regimens.
AIDS research and human retroviruses - 20 Sept 2001
Fitzgibbon J E, Gaur S, Walsman S M, Janahi M, Whitley-Williams P, John J F
Abstract excerpt
HIV-1-infected children are often treated with therapy regimens including protease inhibitors (PIs). We monitored the virologic response in a small group of pediatric patients undergoing therapy with regimens including the PI nelfinavir and determined whether new drug resistance mutations were present immediately after virologic failure. Seventeen reverse transcriptase inhibitor (RTI)-experienced children...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.